Skip to content

DR. RIVERO

Active Private limited companyfounded 2007active for 19 yearsOostlaan 43, 3600 GenkKBO/BCE: BE 0892.572.125

Lifetime

19 annual accounts with figures on one time axis
peak of €627,550 in 2025
€627,550▲ 0.5%
lowest -€4,454 in 2007
€391,138▲ 16.9%
peak of €1.8m in 2025
€1.8m▲ 1.7%
€1.4m▲ 25.9%
Board1 name since 2007
1 director
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Dividend €361,593Debts from €1.1m to €1.4m

Key points

from the 2025 annual accounts

Equity

€1.8m ▲ 1.7%
1.82024+0.4Profit-0.4Dividend1.82025

DR. RIVERO paid out €361,593 in dividends. That is 92% of the 2025 profit.

Turnover

≈ €940,000 estimated

The accounts state no turnover.

Debts

€1.4m ▲ 25.9%
Taxes and wages
+0.02
Suppliers
+0.00
The rest
+0.3

Debts rose by €285,561 in 2025.

Liquidity

3.33 was 7.84 in 2024

Short-term debts rose from €208,214 to €598,850.

Filings

19 annual accounts since 2007
AprilJune31 JulyOctober2010201520202025

Four of the last ten came late. The 2019 accounts came in latest, 119 days after the end of the period.

Position in the sector

€391,138

Higher net result than 95% of companies in human health. The sector median is €59,541, over 21,360 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as DR. RIVERO has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for DR. RIVERO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 05-10-2007

Shares in 1 company,

Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0892572125
changes role from statutory manager to director General meeting of 27-12-2023 · Gazette deed
Incorporation published on 15-10-2007 · Gazette deed
All 29 events

Comparable companies

same main activity, similar in size and age
Company
DR. RIVERO Genk €3.2m €627,550 56.5% -
RADIOLOGIE DR. GENIETS Herzele €3.2m €627,420 81.4% -
DR.DAENEN & DR.MOL Turnhout €3.1m €628,253 93.4% -
DOKTER AN NOLLET Ypres €3.2m €605,877 83.6% -
DOKTER MICHIEL MARCHAU EN DOKTER VéRONIQUE JACOBS Brakel €3.1m €570,352 94.5% -
DR. SOPHIA STEYAERT Ghent €2.9m €619,502 96.1% -
DR. DHONDT ERIK Torhout €2.8m €601,854 87.6% -

These companies have the same main activity as DR. RIVERO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.8m and €3.2m, founded between 2005 and 2008.

Official details

Source: KBO
Status
Active since 24-09-2007Normal situation
Activity
Specialist medical practiceNACE 86220and 1 other
Financial year end
31 December
Peppol
Reachable since 04-11-2024
Company details

Annual accounts 2025

€3.2m▲ 11.0%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on DR. RIVERO

DR. RIVERO files the micro format. That format states no turnover. The gross margin rose from €12,006 in 2007 to €627,550 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. RIVERO

What is the company number of DR. RIVERO?
The company number of DR. RIVERO is 0892.572.125. The VAT number is the same number with BE in front: BE 0892.572.125.
Where is DR. RIVERO based?
The registered office is at Oostlaan 43, 3600 Genk.Company details
What does DR. RIVERO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. RIVERO?
DR. RIVERO is a private limited company (BV).
When was DR. RIVERO founded?
DR. RIVERO was founded on 24-09-2007.
Is DR. RIVERO still active?
Yes, DR. RIVERO is an active enterprise in the KBO register.
What is the turnover of DR. RIVERO?
The turnover in financial year 2025 is about €940,000. This figure is estimated from the gross margin of €627,550 and 31 comparable companies (NACE 86220). It probably lies between €840,000 and €1.3m.Financials
Is DR. RIVERO profitable?
In financial year 2025, DR. RIVERO made a profit of €391,138.
Where can I find the annual accounts of DR. RIVERO?
DR. RIVERO filed 19 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. RIVERO due?
DR. RIVERO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.